AUTL - Autolus Therapeutics plc

QQQ $ 450.41 $ 1.49 (0.33 %)

DIA $ 398.32 $ 0.45 (0.11 %)

SPY $ 527.97 $ 2.05 (0.39 %)

TLT $ 91.99 $ 0.15 (0.16 %)

GLD $ 220.68 $ 1.44 (0.66 %)

Previous Close

$ 3.93

Open

$ 4.14

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 3.99 - $ 4.16

52 Week Range

$ 2.01 - $ 7.45

Volume

1,008,063

Average Volume

Market Cap

1.05B

Beta (5Y Monthly)

$ 1.77

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	03-21-2024	12-31-2023	10-K
2	11-09-2023	09-30-2023	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

$autolus-therapeutics-presents-3-clinical-data-updates-on-obe-cel-in-relapsedrefractory-b-cell-acute-lymphoblastic-leukemia-patients-at-the-2024-eha-congress-june-13-16-2024$

Autolus Therapeutics Presents 3 Clinical D...
05/14/2024 14:05:28

Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell...

Autolus Therapeutics Delays Its First Quar...
05/13/2024 11:27:26

The Company is canceling its previously announced earnings release and call scheduled for before U.S. market open on May 14, 20...

Autolus Therapeutics Announces Abstract Fo...
04/24/2024 14:04:16

Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell...

Needham Reiterates Buy on Autolus Therapeu...
04/12/2024 10:01:53

Needham analyst Gil Blum reiterates Autolus Therapeutics (NASDAQ:AUTL) with a Buy and maintains $9 price target.

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
04/11/2024 20:31:16

Truist Securities Maintains Buy on Autolus...
04/09/2024 17:41:03

Truist Securities analyst Gil Blum maintains Autolus Therapeutics (NASDAQ:AUTL) with a Buy and raises the price target from ...

$autolus-therapeutics-announced-acceptance-of-marketing-authorization-application-by-european-medicines-agency-for-obecabtagene-autoleucel-for-patients-with-relapsedrefractory-adult-b-cell-acute-lymphoblastic-leukemia$

Autolus Therapeutics Announced Acceptance ...
04/02/2024 11:07:56

Autolus Therapeutics Plc Files For Resale ...
03/28/2024 20:22:41

S-3ASR

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
03/20/2024 13:05:56

Breaking Down Autolus Therapeutics: 4 Anal...
03/18/2024 16:01:10

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
03/15/2024 21:33:52

Needham Maintains Buy on Autolus Therapeut...
03/14/2024 19:28:25

Needham analyst Gil Blum maintains Autolus Therapeutics (NASDAQ:AUTL) with a Buy and maintains $9 price target.

Autolus Therapeutics Reports Net Loss Per ...
03/14/2024 11:07:38

Earnings Scheduled For March 14, 2024
03/14/2024 09:52:13

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

Autolus Therapeutics's Earnings Outlook
03/13/2024 16:00:58

Following Most Recent GMP Inspection By MH...
03/12/2024 11:13:10

Autolus Therapeutics Option Alert: Mar 15 ...
02/12/2024 15:20:54

Needham Maintains Buy on Autolus Therapeut...
02/12/2024 11:34:52

Needham analyst Gil Blum maintains Autolus Therapeutics (NASDAQ:AUTL) with a Buy and raises the price target from $8 to $9.

Autolus Therapeutics Announced The Pricing...
02/08/2024 12:05:38

BioNTech, Autolus Announce Strategic CAR-T...
02/08/2024 10:47:56